Pressure BioSciences Inc.

Public Company, Headquarters Location
14 Norfolk Ave., South Easton, MA 02375-1907, United States
(508)230-1828, (508)230-1829 fax, http://www.pressurebiosciences.com

Primary SIC: In Vitro & In Vivo Diagnostic Agents, Primary NAICS: In-Vitro Diagnostic Substance Manufacturing
Description: Manufacturing: Medical test kits for detection and treatment of infectious diseases.

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

Pressure BioSciences Inc., News and Information

PRESSURE BIOSCIENCES REPORTS ACQUISITION BY DIRECTOR FRITZSCHE (Massachusetts)
US Fed News Service, Including US State News; 12/5/2009; 298 words; WASHINGTON, Dec. 5 -- Pressure Biosciences Inc. (PBIO), South Easton, Mass., has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial...

Reportlinker Adds HPLC Systems & Accessories - A World Market Review.
PR Newswire; 12/2/2009; 1851 words; ...Review" by BizAcumen, Inc. Our reports are designed...OUTLOOK 4 Performing Under Pressure: The Versatile HPLC 4 Market...18 Agilent Technologies, Inc. (USA) 18 Dionex Corp. (USA) 18 ESA Biosciences, Inc. (USA) 18 Hitachi High...

Strategies for Building Early-Stage Pharmaceutical Pipelines Through External Sources.
M2 Presswire; 11/20/2009; 999 words; ...announced the addition of Decision Resources, Inc.'s new report "Strategies for Building...to their offering. Under tremendous pressure to refuel dwindling development pipelines...Alnylam Pharmaceuticals - Amgen - Ardea Biosciences - Astellas Pharma - Astex Technology...

Research and Markets: Strategies for Building Early-Stage Pharmaceutical Pipelines Through External Sources.
Business Wire; 11/20/2009; 917 words; ...announced the addition of Decision Resources, Inc.'s new report "Strategies for Building...to their offering. Under tremendous pressure to refuel dwindling development pipelines...Alnylam Pharmaceuticals * Amgen * Ardea Biosciences * Astellas Pharma * Astex Technology...

Pressure BioSciences, Inc. Receives Over $1.1 million From the Initial Tranche of Private Placement.
Investrend; 11/19/2009; 686 words; ...www.financialwire.net/2009/11/19/pressure-biosciences-inc-receives-over-1-1-million-from-the...November 19, 2009 (FinancialWire) -- Pressure BioSciences, Inc. (NASDAQ: PBIO) has closed on the sale of...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.